JPH0412991B2 - - Google Patents
Info
- Publication number
- JPH0412991B2 JPH0412991B2 JP32878388A JP32878388A JPH0412991B2 JP H0412991 B2 JPH0412991 B2 JP H0412991B2 JP 32878388 A JP32878388 A JP 32878388A JP 32878388 A JP32878388 A JP 32878388A JP H0412991 B2 JPH0412991 B2 JP H0412991B2
- Authority
- JP
- Japan
- Prior art keywords
- electrode
- cover
- electrical conductor
- fixation element
- selected location
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000004020 conductor Substances 0.000 claims description 37
- 238000003780 insertion Methods 0.000 claims description 20
- 230000037431 insertion Effects 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 14
- 210000001124 body fluid Anatomy 0.000 claims description 13
- 239000010839 body fluid Substances 0.000 claims description 12
- 238000002844 melting Methods 0.000 claims description 11
- 230000008018 melting Effects 0.000 claims description 11
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 6
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 6
- 230000036760 body temperature Effects 0.000 claims description 6
- 238000004873 anchoring Methods 0.000 claims description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 4
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- LKDRXBCSQODPBY-AMVSKUEXSA-N L-(-)-Sorbose Chemical compound OCC1(O)OC[C@H](O)[C@@H](O)[C@@H]1O LKDRXBCSQODPBY-AMVSKUEXSA-N 0.000 claims description 3
- 239000001103 potassium chloride Substances 0.000 claims description 3
- 235000011164 potassium chloride Nutrition 0.000 claims description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 claims description 3
- 239000011780 sodium chloride Substances 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 2
- 239000008121 dextrose Substances 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 230000001698 pyrogenic effect Effects 0.000 claims description 2
- 239000008103 glucose Substances 0.000 claims 2
- 230000000149 penetrating effect Effects 0.000 claims 1
- -1 sutucarose Chemical compound 0.000 claims 1
- 230000002792 vascular Effects 0.000 claims 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 13
- 235000010355 mannitol Nutrition 0.000 description 11
- 239000002775 capsule Substances 0.000 description 10
- 239000000243 solution Substances 0.000 description 8
- 238000004090 dissolution Methods 0.000 description 7
- 210000001174 endocardium Anatomy 0.000 description 7
- 210000002216 heart Anatomy 0.000 description 7
- 210000004204 blood vessel Anatomy 0.000 description 6
- 238000001990 intravenous administration Methods 0.000 description 6
- 239000000853 adhesive Substances 0.000 description 5
- 230000001070 adhesive effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 238000002513 implantation Methods 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- 235000000346 sugar Nutrition 0.000 description 4
- 150000008163 sugars Chemical class 0.000 description 4
- 229930195725 Mannitol Natural products 0.000 description 3
- 229910001260 Pt alloy Inorganic materials 0.000 description 3
- 230000000747 cardiac effect Effects 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 238000003618 dip coating Methods 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- WABPQHHGFIMREM-UHFFFAOYSA-N lead(0) Chemical compound [Pb] WABPQHHGFIMREM-UHFFFAOYSA-N 0.000 description 3
- 239000000594 mannitol Substances 0.000 description 3
- 239000000155 melt Substances 0.000 description 3
- 230000035515 penetration Effects 0.000 description 3
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 2
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 2
- 238000005266 casting Methods 0.000 description 2
- 238000007598 dipping method Methods 0.000 description 2
- 229960002442 glucosamine Drugs 0.000 description 2
- 210000003709 heart valve Anatomy 0.000 description 2
- 238000001746 injection moulding Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 229910000990 Ni alloy Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000005489 elastic deformation Effects 0.000 description 1
- 230000003176 fibrotic effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 238000011866 long-term treatment Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000012778 molding material Substances 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000003270 subclavian artery Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- 210000002073 venous valve Anatomy 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
- 238000004804 winding Methods 0.000 description 1
Landscapes
- Electrotherapy Devices (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP32878388A JPH02185265A (ja) | 1988-12-26 | 1988-12-26 | 心臓整調電極の溶解可能のカバー |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP32878388A JPH02185265A (ja) | 1988-12-26 | 1988-12-26 | 心臓整調電極の溶解可能のカバー |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH02185265A JPH02185265A (ja) | 1990-07-19 |
| JPH0412991B2 true JPH0412991B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1992-03-06 |
Family
ID=18214076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP32878388A Granted JPH02185265A (ja) | 1988-12-26 | 1988-12-26 | 心臓整調電極の溶解可能のカバー |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH02185265A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108472483A (zh) * | 2015-11-30 | 2018-08-31 | 神经毫微股份公司 | 避免出血的微电极 |
-
1988
- 1988-12-26 JP JP32878388A patent/JPH02185265A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPH02185265A (ja) | 1990-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4827940A (en) | Soluble covering for cardiac pacing electrode | |
| US4876109A (en) | Soluble covering for cardiac pacing electrode | |
| US5473812A (en) | Method of manufacturing medical electrical lead having a torque indicator | |
| EP0939658B1 (en) | Medical electrical lead | |
| US7177704B2 (en) | Pacing method and apparatus | |
| JP4112806B2 (ja) | 心臓ペーシングを行なうことができる恒久的移植可能静脈内リード及び心調律管理装置 | |
| US5531783A (en) | Pacing lead with x-ray visible soluble covering and method of inserting same into a patient's heart | |
| US5908447A (en) | Breakaway structure for body implantable medical device | |
| US6078840A (en) | Medical electrical lead having improved fixation | |
| AU682090B2 (en) | Floating myocardial electrode for implantable pulse generator | |
| US6136021A (en) | Expandable electrode for coronary venous leads | |
| US6711443B2 (en) | Implantable coronary sinus lead and method of implant | |
| US6738674B2 (en) | Implantable coronary sinus lead with mapping capabilities | |
| US7736198B2 (en) | Method of deployable medical lead fixation | |
| US6298272B1 (en) | High impedance electrode tip with internal drug delivery capability | |
| EP1070515B1 (en) | Implantable electrode lead | |
| US6551269B2 (en) | Introducer catheter lead delivery device with collapsible stylet lumen | |
| JPH0412991B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | ||
| US5942276A (en) | Method of manufacturing x-ray visible soluble covering | |
| DE3885738T2 (de) | Lösliche Umhüllung für Herzschrittmacherelektroden. | |
| HK1196318A (en) | Left ventricular intraseptal stimulation lead | |
| HK1196318B (en) | Left ventricular intraseptal stimulation lead |